Open
100% FREE Demat Account

Mankind Pharma IPO: India’s 4th largest pharmaceutical company announces IPO, Golden chance for investors

5/5 - (1 vote)

Mankind Pharma, India’s 4th largest pharmaceutical company, IPO is about to come. Investors were eagerly waiting for this IPO, now that time has come, To get complete information read this news till the end.

Basically Mankind Pharma is a pharmaceutical company based in India, founded in 1995 by R.C. Juneja. The company specializes in manufacturing and marketing pharmaceuticals, over-the-counter (OTC) products, and medical devices. Mankind Pharma has a wide range of products in various therapeutic categories such as anti-infectives, gastrointestinal, cardiovascular, respiratory, and central nervous system. The company has a strong presence in India and also exports its products to more than 30 countries worldwide.

For more details about the Market Updates, join our telegram channel –

Mankind Pharma IPO Details

IPOMankind Pharma
Bidding Dates25 April 2023 – 27 April 2023
Minimum Investment ₹13,338
Price Range ₹1,026 – ₹1,080
Lot Size 13
Issue Size 4326 crore

Mankind Pharma IPO bidding event that will take place from April 25, 2023 to April 27, 2023. The minimum investment required to participate in this event is ₹13,338 crore. The price range for the bidding event is between ₹1,026 and ₹1,080.

The lot size for the bidding event is 13. And the issue size for the bidding event is ₹4,326 crore. This likely refers to the total amount of the financial instrument that is being offered in the bidding event.

Disclaimer: While these IPO is attractive, investors should exercise caution and conduct thorough research before making any investment decisions. It is essential to evaluate a company’s financial health, growth prospects before investing.

Also Read –

Know Why To Become A Life Insurance Consultant
Efix Invest

Efix Invest

Get the latest stock market news, stock information & quotes, data analysis reports, as well as a general overview of the market landscape from EfixInvest.com

Leave a Comment

x